Aditxt, Inc. (NASDAQ:ADTX – Get Free Report) was the target of a large growth in short interest in October. As of October 15th, there was short interest totalling 450,400 shares, a growth of 7,665.5% from the September 30th total of 5,800 shares. Approximately 10.7% of the company’s stock are short sold. Based on an average trading volume of 1,810,000 shares, the short-interest ratio is currently 0.2 days.
Aditxt Price Performance
NASDAQ ADTX opened at $0.80 on Friday. Aditxt has a 52-week low of $0.79 and a 52-week high of $380.00. The firm has a 50-day moving average price of $14.79 and a 200 day moving average price of $53.37.
Aditxt (NASDAQ:ADTX – Get Free Report) last issued its earnings results on Monday, August 19th. The company reported ($167.60) earnings per share (EPS) for the quarter. The firm had revenue of $0.04 million during the quarter.
Insider Transactions at Aditxt
About Aditxt
Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.
See Also
- Five stocks we like better than Aditxt
- How to Calculate Stock Profit
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- What Does a Stock Split Mean?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
- How to Plot Fibonacci Price Inflection Levels
- The Downtrend in UPS Stock Isn’t Over Yet
Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.